Tag: Novartis
Biosimilar biotech company achieves first approval success
Frankfurt It is not every day that German biotech companies receive product approvals for their new drug developments. The Munich Formycon has now achieved such a success both in the…
Novartis wants to spin off its generics division and take it public
Novartis The Swiss pharmaceutical company is likely to focus on high-margin new drugs in the future. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis wants to spin off its business…
Novartis wants to spin off its generics division and take it public
Novartis The Swiss pharmaceutical company is likely to focus on high-margin new drugs in the future. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis wants to spin off its business…
How the Capital Growth Fund outperforms the competition
Stock exchange Euronext in Paris The Capital Growth Fund invests specifically in a small number of European stocks. (Photo: Polaris/laif) Frankfurt Fast trading in hectic stock market times is not…
Fever juice for children is running out
Frankfurt Fever and pain-relieving juices for children are hard to come by in many pharmacies. While liquid preparations with the active ingredient paracetamol were initially affected, juices with the active…
Fever juice for children is running out
Frankfurt Fever and pain-relieving juices for children are hard to come by in many pharmacies. While liquid preparations with the active ingredient paracetamol were initially affected, juices with the active…
Roche: New boss and chairman of the board
Thomas Schinecker In Roche’s diagnostics business, the manager recommended himself for higher positions at the pharmaceutical company. (Photo: Roche) Basel Management change at the pharmaceutical company Roche: After 15 years…
Big Pharma is boosting the blockbuster business with spin-offs
Frankfurt The pharmaceutical industry is in the middle of a profound structural change. The leading companies in the industry are increasingly specializing in drug production. And part with fringe activities…
“Acquisitions are always an option”
Production at Fresenius Kabi The business of the drug division of the group is expected to grow significantly. (Photo: Fresenius) Frankfurt The healthcare group Fresenius intends to play a key…
Eli Lilly is the new star of the pharmaceutical industry
Frankfurt In the past two years, the headlines in the pharmaceutical industry have been dominated by the American industry leader Pfizer with its Covid vaccine Comirnaty – developed together with…
Evotec seals billion-euro deal with BMS for protein destroyers
Frankfurt With a new deal worth billions, the German biotech company Evotec is expanding its existing alliance with the US pharmaceutical giant Bristol-Myers Squibb (BMS) in the field of “protein…
Why Germany is not participating in the EU project
Berlin A video conference can hardly be better equipped. Among others, the then Chancellor Angela Merkel (CDU), French President Emmanuel Macron, EU Commission President Ursula von der Leyen and Biontech…
Bayer frees itself from Monsanto charges
Bayer Over the course of the year, Bayer achieved an operational turnaround and laid a good foundation for further growth in all three divisions. Dusseldorf After the shock of glyphosate…
Formycon wants to become a player in the biosimilar business
In the laboratory After Lucentis, Formycon also wants to launch biosimilars for Stelara and the eye drug Eylea by the middle of the decade. Frankfurt It is not only the…
New remedies for heart failure, cancer, schizophrenia
Frankfurt After several important advances in product development, the pharmaceutical group Boehringer Ingelheim sees itself at the beginning of a new investment offensive in the area of product development and…
Novartis reorganizes itself and fires three top managers
Novartis boss Vasant Narasimhan (Photo: imago images/IP3press) Zurich The Swiss pharmaceutical company Novartis is realigning its core business. In the business with patent-protected drugs – called Innovative Medicines – the…
Swiss equities as a safe haven in times of crisis
Production at Nestlé, Roche, Novartis and Givaudan Swiss stocks from the pharmaceutical and food sectors are considered crisis-resistant. (Photo: AFP/Getty Images) Frankfurt. The Swiss financial market has the reputation of…
How investors can benefit from the value trend
Price movement in the markets So-called “value” stocks are currently in demand – investors can react accordingly by adjusting their ETF portfolio. (Photo: Getty Images) Frankfurt Is the long boom…
How investors can benefit from the value trend
Price movement in the markets So-called “value” stocks are currently in demand – investors can react accordingly by adjusting their ETF portfolio. (Photo: Getty Images) Frankfurt Is the long boom…
Corona boom brings record growth to pharmaceutical industry
Frankfurt In 2021, the corona pandemic gave the pharmaceutical industry the biggest jump in sales in decades. Overall, the industry generated additional sales of almost $100 billion last year with…